Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function

Virology

Volumn 229, Issue 1, 1997, Pages 77-89

  Lyles, Douglas S ^a   McKenzie, Margie O ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

M PROTEIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS MUTANT; VIRUS PATHOGENESIS;

ANIMALIA; VESICULAR STOMATITIS VIRUS;

EID: 0031550792     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8415     Document Type: Article

References (24)

1. Black, B. L., and Lyles, D. S. (1992). Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J. Virol. 66, 4058-4064.
2. Black, B. L., Rhodes, R. B., McKenzie, M., and Lyles, D. S. (1993). The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its role in virus assembly. J. Virol. 67, 4814-4821.
3. Black, B. L., Brewer, G., and Lyles, D. S. (1994). Effect of vesicular stomatitis virus matrix protein on host-directed translation in vivo. J. Virol. 68, 555-560.
4. Blondel, D., Harmison, G. H., and Schubert, M. (1990). Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J. Virol. 64, 1716-1725.
5. Coulon, P., Deutsch, V., Lafay, F., Martinet-Edelist, C., Wyers, F., Herman, R. C., and Ramand, A. (1990). Genetic evidence for multiple functions of the matrix protein of vesicular stomatitis virus. J. Gen. Virol. 71, 991-996.
6. Ferran, M. C., and Lucas-Lenard, J. M. (1997). The vesicular stomatitis virus matrix protein inhibits transcription from the human interferon-β promoter. J. Virol., 71, 371-377.
7. Francoeur, A. M., Poliquin, L., and Stanners, C. P. (1987). The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis. Virology 160, 236-245.
8. Kaptur, P. E., McKenzie, M. O., Wertz, G. W., and Lyles, D. S. (1995). Assembly functions of vesicular stomatitis virus matrix protein are not disrupted by mutations at major sites of phosphorylation. Virology 206, 894-903.
9. Koyama, A. H. (1995). Induction of apoptotic DNA fragmentation by the infection of vesicular stomatitis virus. Virus Res. 37, 285-290.
10. Lenard, J. (1996). Negative-strand virus M and retrovirus MA proteins: All in a family? Virology 216, 289-298.
11. Lyles, D. S., Puddington, L., and McCreedy, B. J. (1988). Vesicular stomatitis virus M protein in the nuclei of infected cells. J. Virol. 62, 4387-4392.
12. Lyles, D. S., McKenzie, M. O., Ahmed, M., and Woolwine, S. C. (1996). Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression. Virology, 225, 172-180.
13. Melki, R., Gaudin, Y., and Blondel, D. (1994). Interaction between tubulin and the viral matrix protein of vesicular stomatitis virus: Possible implications in the viral cytopathic effect. Virology 202, 339-347.
14. Paik, S.-Y., Banerjea, A. C., Harmison, G. G., Chen, C.-J., and Schubert, M. (1995). Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. J. Virol. 69, 3529-3537.
15. Poliquin, L., and Dunigan, D. D. (1996). Differential activation of apoptosis by wild type and mutant strains of vesicular stomatitis virus. Abstracts of the American Society for Virology 15th Annual Meeting, p. 118.
16. Razvi, E. S., and Welsh, R. M. (1995). Apoptosis in viral infections. Adv. Virus Res. 45, 2-60.
17. Simon, K. O., Whitaker-Dowling, P. A., Youngner, J. S., and Widnell, C. C. (1990). Sequential disassembly of the cytoskeleton in BHK21 cells infected with vesicular stomatitis virus. Virology 177, 289-297.
18. Sprague, J., Condra, J. H., Arnheiter, H., and Lazzarini, R. A. (1983). Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein. J. Virol. 45, 773-781.
19. Stanners, C. P., Francoeur, A. M., and Lam, T. (1977). Analysis of VSV mutant with attenuated cytopathogenicity: Mutation in viral function, P, for inhibition of protein synthesis. Cell 11, 273-281.
20. Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryere, J. S., Wold, L. J., and Wold, W. S. M. (1996). The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J. Virol. 70, 2296-2306.
21. Wagner, R. R., and Huang, A. S. (1966). Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus. Virology 28, 1-10.
22. Wertz, G. W., and Youngner, J. S. (1970). Interferon production and inhibition of host synthesis in cells infected with vesicular stomatitis virus. J. Virol. 6, 476-484.
23. Weck, P. K., and Wagner, R. R. (1979). Transcription of vesicular stomatitis virus is required to shut off cellular RNA synthesis. J. Virol. 30, 410-413.
24. Ye, Z., Sun, W., Suryanarayana, K., Justice, P., Robinson, D., and Wagner, R. R. (1994). Membrane-binding domains and cytopathogenesis of the matrix protein of vesicular stomatitis virus. J. Virol. 68, 7386-7396.